Tue. 14 May 2024, 4:38pm ET
Benzinga
Earnings, Earnings Misses, News
Vincerx Pharma (NASDAQ:VINC) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimate of $(0.29) by 100 percent. This is a 14.71 percent increase over losses of $(0.68) per share from the same period last year.